Top

Published in:

Open Access 01-10-2018 | Original Paper

Identification of an enhancer region within the TP63/LEPREL1 locus containing genetic variants associated with bladder cancer risk

Authors: Aleksandra M. Dudek, Sita H. Vermeulen, Dimitar Kolev, Anne J. Grotenhuis, Lambertus A. L. M. Kiemeney, Gerald W. Verhaegh

Published in: Cellular Oncology | Issue 5/2018

Abstract

Purpose

Genome-wide association studies (GWAS) have led to the identification of a bladder cancer susceptibility variant (rs710521) in a non-coding intergenic region between the TP63 and LEPREL1 genes on chromosome 3q28, suggesting a role in the transcriptional regulation of these genes. In this study, we aimed to functionally characterize the 3q28 bladder cancer risk locus.

Methods

Fine-mapping was performed by focusing on the region surrounding rs710521, and variants were prioritized for further experiments using ENCODE regulatory data. The enhancer activity of the identified region was evaluated using dual-luciferase assays. CRISPR/Cas9-mediated deletion of the enhancer region was performed and the effect of this deletion on cell proliferation and gene expression levels was evaluated using CellTiter-Glo and RT-qPCR, respectively.

Results

Fine-mapping of the GWAS signal region led to the identification of twenty SNPs that showed a stronger association with bladder cancer risk than rs710521. Using publicly available data on regulatory elements and sequences, an enhancer region containing the bladder cancer risk variants was identified. Through reporter assays, we found that the presence of the enhancer region significantly increased ΔNTP63 promoter activity in bladder cancer-derived cell lines. CRISPR/Cas9-mediated deletion of the enhancer region reduced the viability of bladder cancer cells by decreasing the expression of ΔNTP63 and p63 target genes.

Conclusions

Taken together, our data show that bladder cancer risk-associated variants on chromosome 3q28 are located in an active enhancer region. Further characterization of the allele-specific activity of the identified enhancer and its target genes may lead to the identification of novel signaling pathways involved in bladder carcinogenesis.

Available only for authorised users

J. Ott, J. Wang, S.M. Leal, Genetic linkage analysis in the age of whole-genome sequencing. Nat. Rev. Genet. 16, 275–284 (2015)CrossRefPubMedPubMedCentral

L.A. Kiemeney, S. Thorlacius, P. Sulem, F. Geller, K.K.H. Aben, S.N. Stacey, J. Gudmundsson, M. Jakobsdottir, J.T. Bergthorsson, A. Sigurdsson, T. Blondal, J.A. Witjes, S.H. Vermeulen, C. Hulsbergen-van de Kaa, D.W. Swinkels, M. Ploeg, E.B. Cornel, H. Vergunst, T.E. Thorgeirsson, D. Gudbjartsson, S. Gudjonsson, G. Thorleifsson, K.T. Kristinsson, M. Mouy, S. Snorradottir, D. Placidi, M. Campagna, C. Arici, K. Koppova, E. Gurzau, P. Rudnai, E. Kellen, S. Polidoro, S. Guarrera, C. Sacerdote, M. Sanchez, B. Saez, G. Valdivia, C. Ryk, P. de Verdier, A. Lindblom, K. Golka, D.T. Bishop, M.A. Knowles, S. Nikulasson, V. Petursdottir, E. Jonsson, G. Geirsson, B. Kristjansson, J.I. Mayordomo, G. Steineck, S. Porru, F. Buntinx, M.P. Zeegers, T. Fletcher, R. Kumar, G. Matullo, P. Vineis, A.E. Kiltie, J.R. Gulcher, U. Thorsteinsdottir, A. Kong, T. Rafnar, K. Stefansson, Sequence variant on 8q24 confers susceptibility to urinary bladder cancer. Nat. Genet. 40, 1307–1312 (2008)CrossRefPubMedPubMedCentral

T. Rafnar, P. Sulem, S.N. Stacey, F. Geller, J. Gudmundsson, A. Sigurdsson, M. Jakobsdottir, H. Helgadottir, S. Thorlacius, K.K.H. Aben, T. Blondal, T.E. Thorgeirsson, G. Thorleifsson, K. Kristjansson, K. Thorisdottir, R. Ragnarsson, B. Sigurgeirsson, H. Skuladottir, T. Gudbjartsson, H.J. Isaksson, G.V. Einarsson, K.R. Benediktsdottir, B.A. Agnarsson, K. Olafsson, A. Salvarsdottir, H. Bjarnason, M. Asgeirsdottir, K.T. Kristinsson, S. Matthiasdottir, S.G. Sveinsdottir, S. Polidoro, V. Hoiom, R. Botella-Estrada, K. Hemminki, P. Rudnai, D.T. Bishop, M. Campagna, E. Kellen, M.P. Zeegers, P. de Verdier, A. Ferrer, D. Isla, M.J. Vidal, R. Andres, B. Saez, P. Juberias, J. Banzo, S. Navarrete, A. Tres, D. Kan, A. Lindblom, E. Gurzau, K. Koppova, F. de Vegt, J.A. Schalken, H.F.M. van der Heijden, H. Smit, R.A. Termeer, E. Oosterwijk, O. van Hooij, E. Nagore, S. Porru, G. Steineck, J. Hansson, F. Buntinx, W.J. Catalona, G. Matullo, P. Vineis, A.E. Kiltie, J.I. Mayordomo, R. Kumar, L.A. Kiemeney, M.L. Frigge, T. Jonsson, H. Saemundsson, R.B. Barkardottir, E. Jonsson, S. Jonsson, J.H. Olafsson, J.R. Gulcher, G. Masson, D.F. Gudbjartsson, A. Kong, U. Thorsteinsdottir, K. Stefansson, Sequence variants at the TERT-CLPTM1L locus associate with many cancer types. Nat. Genet. 41, 221–227 (2009)CrossRefPubMedPubMedCentral

L.A. Kiemeney, P. Sulem, S. Besenbacher, S. Vermeulen, A. Sigurdsson, G. Thorleifsson, D. Gudbjartsson, S. Stacey, J. Gudmundsson, C. Zanon, J. Kostic, G. Masson, H. Bjarnason, S.T. Palsson, O.B. Skarphedinsson, S.A. Gudjonsson, J.A. Witjes, A.J. Grotenhuis, G.W. Verhaegh, D.T. Bishop, S.C. Sak, A. Choudhury, F. Elliot, J.H. Barrett, C.D. Hurst, P.J. de Verdier, C. Ryk, P. Rudnai, E. Gurzau, K. Koppova, P. Vineis, S. Polidorio, S. Guarrera, C. Sacardote, M. Campagna, D. Placidi, C. Arici, M.P. Zeegers, E. Kellen, B. Saez Gutierrez, J.I. Sanz-Velez, M. Sanchez-Zalabardo, G. Valvidia, M.D. Garcia-Prats, J.G. Hengstler, M. Blaszkiewicz, H. Dietrich, R.A. Ophoff, L.H. van den Berg, K. Alexiusdottir, K. Kristjansson, G. Geirsson, S. Nikulasson, V. Petursdottir, A. Kong, T. Thorgeirsson, N.A. Mungan, A. Lindblom, M.A. van Es, S. Porru, F. Buntinx, K. Golka, J.I. Mayordomo, R. Kumar, G. Matullo, G. Steineck, A.E. Kiltie, K.K. Aben, E. Jonsson, U. Thorsteinsdottir, M.A. Knowles, T. Rafnar, K. Stefansson, A sequence variant at 4p16.3 confers susceptibility to urinary bladder cancer. Nat. Genet. 42, 415 (2010)CrossRefPubMedPubMedCentral

X. Wu, Y. Ye, L.A. Kiemeney, P. Sulem, T. Rafnar, G. Matullo, D. Seminara, T. Yoshida, N. Saeki, A.S. Andrew, C.P. Dinney, B. Czerniak, Z.F. Zhang, A.E. Kiltie, D.T. Bishop, P. Vineis, S. Porru, F. Buntinx, E. Kellen, M.P. Zeegers, R. Kumar, P. Rudnai, E. Gurzau, K. Koppova, J.I. Mayordomo, M. Sanchez, B. Saez, A. Lindblom, P. de Verdier, G. Steineck, G.B. Mills, A. Schned, S. Guarrera, S. Polidoro, S.C. Chang, J. Lin, D.W. Chang, K.S. Hale, T. Majewski, H.B. Grossman, S. Thorlacius, U. Thorsteinsdottir, K.K. Aben, J.A. Witjes, K. Stefansson, C.I. Amos, M.R. Karagas, J. Gu, Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer. Nat. Genet. 41, 991–995 (2009)CrossRefPubMedPubMedCentral

N. Rothman, M. Garcia-Closas, N. Chatterjee, N. Malats, X. Wu, J.D. Figueroa, F.X. Real, D. Van Den Berg, G. Matullo, D. Baris, M. Thun, L.A. Kiemeney, P. Vineis, I. De Vivo, D. Albanes, M.P. Purdue, T. Rafnar, M.A.T. Hildebrandt, A.E. Kiltie, O. Cussenot, K. Golka, R. Kumar, J.A. Taylor, J.I. Mayordomo, K.B. Jacobs, M. Kogevinas, A. Hutchinson, Z. Wang, Y.P. Fu, L. Prokunina-Olsson, L. Burdett, M. Yeager, W. Wheeler, A. Tardón, C. Serra, A. Carrato, R. García-Closas, J. Lloreta, A. Johnson, M. Schwenn, M.R. Karagas, A. Schned, G. Andriole, R. Grubb, A. Black, E.J. Jacobs, W.R. Diver, S.M. Gapstur, S.J. Weinstein, J. Virtamo, V.K. Cortessis, M. Gago-Dominguez, M.C. Pike, M.C. Stern, J.M. Yuan, D.J. Hunter, M. McGrath, C.P.N. Dinney, B. Czerniak, M. Chen, H. Yang, S.H. Vermeulen, K.K. Aben, J.A. Witjes, R.R. Makkinje, P. Sulem, S. Besenbacher, K. Stefansson, E. Riboli, P. Brennan, S. Panico, C. Navarro, N.E. Allen, H.B. Bueno-de-Mesquita, D. Trichopoulos, N. Caporaso, M.T. Landi, F. Canzian, B. Ljungberg, A. Tjonneland, F. Clavel-Chapelon, D.T. Bishop, M.T.W. Teo, M.A. Knowles, S. Guarrera, S. Polidoro, F. Ricceri, C. Sacerdote, A. Allione, G. Cancel-Tassin, S. Selinski, J.G. Hengstler, H. Dietrich, T. Fletcher, P. Rudnai, E. Gurzau, K. Koppova, S.C.E. Bolick, A. Godfrey, Z. Xu, J.I. Sanz-Velez, M.D. García-Prats, M. Sanchez, G. Valdivia, S. Porru, S. Benhamou, R.N. Hoover, J.F. Fraumeni, D.T. Silverman, S.J. Chanock, A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci. Nat. Genet. 42, 978–984 (2010)CrossRefPubMedPubMedCentral

M. Garcia-Closas, Y. Ye, N. Rothman, J.D. Figueroa, N. Malats, C.P. Dinney, N. Chatterjee, L. Prokunina-Olsson, Z. Wang, J. Lin, F.X. Real, K.B. Jacobs, D. Baris, M. Thun, I. De Vivo, D. Albanes, M.P. Purdue, M. Kogevinas, A.M. Kamat, S.P. Lerner, H.B. Grossman, J. Gu, X. Pu, A. Hutchinson, Y.P. Fu, L. Burdett, M. Yeager, W. Tang, A. Tardón, C. Serra, A. Carrato, R. García-closas, J. Lloreta, A. Johnson, M. Schwenn, M.R. Karagas, A. Schned, G. Andriole, R. Grubb, A. Black, E.J. Jacobs, W.R. Diver, S.M. Gapstur, S.J. Weinstein, J. Virtamo, D.J. Hunter, N. Caporaso, M.T. Landi, J.F. Fraumeni, D.T. Silverman, S.J. Chanock, X. Wu, Genome-wide association study of bladder cancer identifies a new susceptibility locus within SLC14A1, a urea transporter gene on chromosome 18q12.3. Hum. Mol. Genet. 20, 4282–4289 (2011)CrossRefPubMedPubMedCentral

T. Rafnar, S.H. Vermeulen, P. Sulem, G. Thorleifsson, K.K. Aben, J.A. Witjes, A.J. Grotenhuis, G.W. Verhaegh, C.A. Hulsbergen-van de Kaa, S. Besenbacher, D. Gudbjartsson, S.N. Stacey, J. Gudmundsson, H. Johannsdottir, H. Bjarnason, C. Zanon, H. Helgadottir, J.G. Jonasson, L. Tryggvadottir, E. Jonsson, G. Geirsson, S. Nikulasson, V. Petursdottir, D.T. Bishop, S. Chung-Sak, A. Choudhury, F. Elliott, J.H. Barrett, M.A. Knowles, P.J. de Verdier, C. Ryk, A. Lindblom, P. Rudnai, E. Gurzau, K. Koppova, P. Vineis, S. Polidoro, S. Guarrera, C. Sacerdote, A. Panadero, J.I. Sanz-Velez, M. Sanchez, G. Valdivia, M.D. Garcia-Prats, J.G. Hengstler, S. Selinski, H. Gerullis, D. Ovsiannikov, A. Khezri, A. Aminsharifi, M. Malekzadeh, L.H. van den Berg, R.A. Ophoff, J.H. Veldink, M.P. Zeegers, E. Kellen, J. Fostinelli, D. Andreoli, C. Arici, S. Porru, F. Buntinx, A. Ghaderi, K. Golka, J.I. Mayordomo, G. Matullo, R. Kumar, G. Steineck, A.E. Kiltie, A. Kong, U. Thorsteinsdottir, K. Stefansson, L.A. Kiemeney, European genome-wide association study identifies SLC14A1 as a new urinary bladder cancer susceptibility gene. Hum. Mol. Genet. 20, 4268–4281 (2011)CrossRefPubMedPubMedCentral

T. Rafnar, P. Sulem, G. Thorleifsson, S.H. Vermeulen, H. Helgason, J. Saemundsdottir, S.A. Gudjonsson, A. Sigurdsson, S.N. Stacey, J. Gudmundsson, H. Johannsdottir, K. Alexiusdottir, V. Petursdottir, S. Nikulasson, G. Geirsson, T. Jonsson, K.K.H. Aben, A.J. Grotenhuis, G.W. Verhaegh, A.M. Dudek, J.A. Witjes, A.G. van der Heijden, A. Vrieling, T.E. Galesloot, A. De Juan, A. Panadero, F. Rivera, C. Hurst, D.T. Bishop, S.C. Sak, A. Choudhury, M.T.W. Teo, C. Arici, A. Carta, E. Toninelli, P. de Verdier, P. Rudnai, E. Gurzau, K. Koppova, K.A. van der Keur, I. Lurkin, M. Goossens, E. Kellen, S. Guarrera, A. Russo, R. Critelli, C. Sacerdote, P. Vineis, C. Krucker, M.P. Zeegers, H. Gerullis, D. Ovsiannikov, F. Volkert, J.G. Hengstler, S. Selinski, O.T. Magnusson, G. Masson, A. Kong, D. Gudbjartsson, A. Lindblom, E. Zwarthoff, S. Porru, K. Golka, F. Buntinx, G. Matullo, R. Kumar, J.I. Mayordomo, D.G. Steineck, A.E. Kiltie, E. Jonsson, F. Radvanyi, M.A. Knowles, U. Thorsteinsdottir, L.A. Kiemeney, K. Stefansson, Genome-wide association study yields variants at 20p12.2 that associate with urinary bladder cancer. Hum. Mol. Genet. 23, 5545–5557 (2014)CrossRefPubMed

10.

J.D. Figueroa, Y. Ye, A. Siddiq, M. Garcia-closas, N. Chatterjee, L. Prokunina-olsson, V.K. Cortessis, C. Kooperberg, O. Cussenot, S. Benhamou, J. Prescott, S. Porru, C.P. Dinney, N. Malats, D. Baris, M. Purdue, E.J. Jacobs, D. Albanes, Z. Wang, X. Deng, C.C. Chung, W. Tang, H. Bas, D. Trichopoulos, B. Ljungberg, F. Clavel-Chapelon, E. Weiderpass, V. Krogh, M. Dorronsoro, R. Travis, A. Tjønneland, P. Brenan, J. Chang-Claude, E. Riboli, D. Conti, M. Gago-dominguez, M.C. Stern, M.C. Pike, D. Van den Berg, J.M. Yuan, C. Hohensee, R. Rodabough, G. Cancel-Tassin, M. Roupret, E. Comperat, C. Chen, I. De vivo, E. Giovannucci, D.J. Hunter, P. Kraft, S. Lindstrom, A. Carta, S. Pavanello, C. Arici, G. Mastrangelo, A.M. Kamat, S.P. Lerner, H.B. Grossman, J. Lin, J. Gu, X. Pu, A. Hutchinson, L. Burdette, W. Wheeler, M. Kogevinas, A. Tardón, C. Serra, A. Carrato, R. Garcia-Closas, J. Lloreta, M. Schwenn, M.R. Karagas, A. Johnson, A. Schned, K.R. Armenti, G.M. Hosain, G. Andriole, R. Grubb, A. Black, W.R. Diver, S.M. Gapstur, S.J. Weinstein, J. Virtamo, C.A. Haiman, M.T. Landi, N. Caporaso, J.F. Fraumeni, P. Vineis, X. Wu, D.T. Silverman, S. Chanock, N. Rothman, Genome-wide association study identifies multiple loci associated with bladder cancer risk. Hum. Mol. Genet. 23, 1387–1398 (2014)CrossRefPubMed

11.

J.D. Figueroa, C.D. Middlebrooks, A.R. Banday, Y. Ye, M. Garcia-Closas, N. Chatterjee, S. Koutros, L.A. Kiemeney, T. Rafnar, T. Bishop, H. Furberg, G. Matullo, K. Golka, M. Gago-Dominguez, J.A. Taylor, T. Fletcher, A. Siddiq, V.K. Cortessis, C. Kooperberg, O. Cussenot, S. Benhamou, J. Prescott, S. Porru, C.P. Dinney, N. Malats, D. Baris, M.P. Purdue, E.J. Jacobs, D. Albanes, Z. Wang, C.C. Chung, S.H. Vermeulen, K.K. Aben, T.E. Galesloot, G. Thorleifsson, P. Sulem, K. Stefansson, A.E. Kiltie, M. Harland, M. Teo, K. Offit, J. Vijai, D. Bajorin, R. Kopp, G. Fiorito, S. Guarrera, C. Sacerdote, S. Selinski, J.G. Hengstler, H. Gerullis, D. Ovsiannikov, M. Blaszkewicz, J.E. Castelao, M. Calaza, M.E. Martinez, P. Cordeiro, Z. Xu, V. Panduri, R. Kumar, E. Gurzau, K. Koppova, H.B. Bueno-De-Mesquita, B. Ljungberg, F. Clavel-Chapelon, E. Weiderpass, V. Krogh, M. Dorronsoro, R.C. Travis, A. Tjonneland, P. Brennan, J. Chang-Claude, E. Riboli, D. Conti, M.C. Stern, M.C. Pike, D. Van Den Berg, J.M. Yuan, C. Hohensee, R.P. Jeppson, G. Cancel-Tassin, M. Roupret, E. Comperat, C. Turman, I. De Vivo, E. Giovannucci, D.J. Hunter, P. Kraft, S. Lindstrom, A. Carta, S. Pavanello, C. Arici, G. Mastrangelo, A.M. Kamat, L. Zhang, Y. Gong, X. Pu, A. Hutchinson, L. Burdett, W.A. Wheeler, M.R. Karagas, A. Johnson, A. Schned, G.M. Monawar Hosain, M. Schwenn, M. Kogevinas, A. Tardon, C. Serra, A. Carrato, R. Garcia-Closas, J. Lloreta, G. Andriole, G. Robert, A. Black, W.R. Diver, S.M. Gapstur, S. Weinstein, J. Virtamo, C.A. Haiman, M.T. Landi, N.E. Caporaso, F. Joseph, P. Vineis, X. Wu, S.J. Chanock, D.T. Silverman, L. Prokunina-Olsson, N. Rothman, Identification of a novel susceptibility locus at 13q34 and refinement of the 20p12.2 region as a multi-signal locus associated with bladder cancer risk in individuals of european ancestry. Hum. Mol. Genet. 25, 1203–1214 (2016)CrossRefPubMedPubMedCentral

12.

A.M. Dudek, A.J. Grotenhuis, S.H. Vermeulen, L.A. Kiemeney, G.W. Verhaegh, Urinary bladder cancer susceptibility markers. What do we know about functional mechanisms? Int. J. Mol. Sci. 14, 12346–12366 (2013)CrossRefPubMedPubMedCentral

13.

Y.P. Fu, I. Kohaar, N. Rothman, J. Earl, J.D. Figueroa, Y. Ye, N. Malats, W. Tang, L. Liu, M. Garcia-Closas, B. Muchmore, N. Chatterjee, M. Tarway, M. Kogevinas, P. Porter-Gill, D. Baris, A. Mumy, D. Albanes, M.P. Purdue, A. Hutchinson, A. Carrato, A. Tardon, C. Serra, R. Garcia-Closas, J. Lloreta, A. Johnson, M. Schwenn, M.R. Karagas, A. Schned, W.R. Diver, S.M. Gapstur, M.J. Thun, J. Virtamo, S.J. Chanock, J.F. Fraumeni Jr., D.T. Silverman, X. Wu, F.X. Real, L. Prokunina-Olsson, Common genetic variants in the PSCA gene influence gene expression and bladder cancer risk. Proc. Natl. Acad. Sci. U.S.A. 109, 4974–4979 (2012)CrossRefPubMedPubMedCentral

14.

Y.P. Fu, I. Kohaar, L.E. Moore, P. Lenz, J.D. Figueroa, W. Tang, P. Porter-Gill, N. Chatterjee, A. Scott-Johnson, M. Garcia-Closas, B. Muchmore, D. Baris, A. Paquin, K. Ylaya, M. Schwenn, A.B. Apolo, M.R. Karagas, M. Tarway, A. Johnson, A. Mumy, A. Schned, L. Guedez, M.A. Jones, M. Kida, G.M.M. Hosain, N. Malats, M. Kogevinas, A. Tardon, C. Serra, A. Carrato, R. Garcia-Closas, J. Lloreta, X. Wu, M. Purdue, G.L. Andriole, R.L. Grubb, A. Black, M.T. Landi, N.E. Caporaso, P. Vineis, A. Siddiq, H.B. Bueno-de-Mesquita, D. Trichopoulos, B. Ljungberg, G. Severi, E. Weiderpass, V. Krogh, M. Dorronsoro, R.C. Travis, A. Tjonneland, P. Brennan, J. Chang-Claude, E. Riboli, J. Prescott, C. Chen, I. De Vivo, E. Govannucci, D. Hunter, P. Kraft, S. Lindstrom, S.M. Gapstur, E.J. Jacobs, W.R. Diver, D. Albanes, S.J. Weinstein, J. Virtamo, C. Kooperberg, C. Hohensee, R.J. Rodabough, V.K. Cortessis, D.V. Conti, M. Gago-Dominguez, M.C. Stern, M.C. Pike, D. Van Den Berg, J.M. Yuan, C.A. Haiman, O. Cussenot, G. Cancel-Tassin, M. Roupret, E. Comperat, S. Porru, A. Carta, S. Pavanello, C. Arici, G. Mastrangelo, H.B. Grossman, Z. Wang, X. Deng, C.C. Chung, A. Hutchinson, L. Burdette, W. Wheeler, J. Fraumeni, S.J. Chanock, S.M. Hewitt, D.T. Silverman, N. Rothman, L. Prokunina-Olsson, The 19q12 bladder cancer GWAS signal: association with cyclin E function and aggressive disease. Cancer Res. 74, 5808–5818 (2014)CrossRefPubMedPubMedCentral

15.

W. Tang, Y.P. Fu, J.D. Figueroa, N. Malats, M. Garcia-Closas, N. Chatterjee, M. Kogevinas, D. Baris, M. Thun, J.L. Hall, I. De Vivo, D. Albanes, P. Porter-Gill, M.P. Purdue, L. Burdett, L. Liu, A. Hutchinson, T. Myers, A. Tard́on, C. Serra, A. Carrato, R. Garcia-closas, J. Lloreta, A. Johnson, M. Schwenn, M.R. Karagas, A. Schned, A. Black, E.J. Jacobs, W.R. Diver, S.M. Gapstur, J. Virtamo, D.J. Hunter, J.F. Fraumeni, S.J. Chanock, D.T. Silverman, N. Rothman, L. Prokunina-Olsson, Mapping of the UGT1A locus identifies an uncommon coding variant that affects mRNA expression and protects from bladder cancer. Hum. Mol. Genet. 21, 1918–1930 (2012)CrossRefPubMedPubMedCentral

16.

C. Middlebrooks, A. Banday, K. Matsuda, K. Udquim, O. Onabajo, A. Paquin, J.D. Figueroa, B. Zhu, S. Koutros, M. Kubo, T. Shuin, N.D. Freedman, M. Kogevinas, N. Malats, S.J. Chanock, M. Garcia-Closas, D.T. Silverman, N. Rothman, L. Prokunina-Olsson, Association of germline variants in the APOBEC3 region with cancer risk and enrichment with APOBEC-signature mutations in tumors. Nat. Genet. 48, 1330–1338 (2016)CrossRefPubMed

17.

ENCODE Project Consortium, An integrated encyclopedia of DNA elements in the human genome. Nature 489, 57–74 (2012)CrossRef

18.

M.T. Maurano, R. Humbert, E. Rynes, R.E. Thurman, E. Haugen, H. Wang, A.P. Reynolds, R. Sandstrom, H. Qu, J. Brody, A. Shafer, F. Neri, K. Lee, T. Kutyavin, S. Stehling-Sun, A.K. Johnson, T.K. Canfield, E. Giste, M. Diegel, D. Bates, R.S. Hansen, S. Neph, P.J. Sabo, S. Heimfeld, A. Raubitschek, S. Ziegler, C. Cotsapas, N. Sotoodehnia, I. Glass, S.R. Sunyaev, R. Kaul, J.A. Stamatoyannopoulos, Systematic localization of common disease-associated variation in regulatory DNA. Science 337, 1190–1195 (2012)CrossRefPubMedPubMedCentral

19.

L.D. Ward, M. Kellis, HaploReg: A resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants. Nat. Biotechnol. 40, D930–D934 (2012)

20.

I. Tomlinson, E. Webb, L. Carvajal-Carmona, P. Broderick, Z. Kemp, S. Spain, S. Penegar, I. Chandler, M. Gorman, W. Wood, E. Barclay, S. Lubbe, L. Martin, G. Sellick, E. Jaeger, R. Hubner, R. Wild, A. Rowan, S. Fielding, K. Howarth, C.O.R.G.I. Consortium, A. Silver, W. Atkin, K. Muir, R. Logan, D. Kerr, E. Johnstone, O. Sieber, R. Gray, H. Thomas, J. Peto, J.B. Cazier, R. Houlston, A genome-wide association scan of tag SNPs identifies a susceptibility variant for colorectal cancer at 8q24.21. Nat. Genet. 39, 984–988 (2007)CrossRefPubMed

21.

S. Tuupanen, M. Turunen, R. Lehtonen, O. Hallikas, S. Vanharanta, T. Kivioja, M. Björklund, G. Wei, J. Yan, I. Niittymäki, J.P. Mecklin, H. Järvinen, A. Ristimäki, M. Di-Bernardo, P. East, L. Carvajal-Carmona, R.S. Houlston, I. Tomlinson, K. Palin, E. Ukkonen, A. Karhu, J. Taipale, L.A. Aaltonen, The common colorectal cancer predisposition SNP rs6983267 at chromosome 8q24 confers potential to enhanced Wnt signaling. Nat. Genet. 41, 885–890 (2009)CrossRefPubMed

22.

M.M. Pomerantz, N. Ahmadiyeh, L. Jia, P. Herman, M.P. Verzi, H. Doddapaneni, C.A. Beckwith, J.A. Chan, A. Hills, M. Davis, K. Yao, S.M. Kehoe, H.J. Lenz, C.A. Haiman, C. Yan, B.E. Henderson, B. Frenkel, J. Barretina, A. Bass, J. Tabernero, J. Baselga, M.M. Regan, J.R. Manak, R. Shivdasani, G.A. Coetzee, M.L. Freedman, The 8q24 cancer risk variant rs6983267 shows long-range interaction with MYC in colorectal cancer. Nat. Genet. 41, 882–884 (2009)CrossRefPubMedPubMedCentral

23.

J.B. Wright, S.J. Brown, M.D. Cole, Upregulation of c-MYC in cis through a large chromatin loop linked to a cancer risk-associated single-nucleotide polymorphism in colorectal cancer cells. Mol. Cell. Biol. 30, 1411–1420 (2010)CrossRefPubMedPubMedCentral

24.

Y. Takatsuno, K. Mimori, K. Yamamoto, T. Sato, A. Niida, H. Inoue, S. Imoto, S. Kawano, R. Yamaguchi, H. Toh, H. Iinuma, S. Ishimaru, H. Ishii, S. Suzuki, S. Tokudome, M. Watanabe, J. Tanaka, S.E. Kudo, H. Mochizuki, M. Kusunoki, K. Yamada, Y. Shimada, Y. Moriya, S. Miyano, K. Sugihara, M. Mori, The rs6983267 SNP is associated with MYC transcription efficiency, which promotes progression and worsens prognosis of colorectal cancer. Ann. Surg. Oncol. 20, 1395–1402 (2013)CrossRefPubMed

25.

R. Redis, L. Vela, W. Lu, F. de Oliveira, C. Ivan, C. Rodriguez-Aguayo, D. Adamoski, B. Pasculli, A. Taguchi, Y. Chen, A.F. Fernandex, L. Valledorm, K. Van Roosbroeck, S. Chang, M. Shah, G. Kinnebrew, L. Han, Y. Atlasi, L.H. Cheung, G.Y. Huang, M.S. Ramirez, T. Catela Ivkovic, L. Van, H. Ling, R. Gafa, S. Kapitanovic, G. Lanza, J.A. Bankson, P. Huang, S.Y. Lai, R.C. Bast, M.G. Rosenblum, M. Radovich, M. Ivan, G. Bartholomeusz, H. Liang, M.F. Fraga, W.R. Widger, S. Hanash, I. Berindan-Neagoe, G. Lopez-Berenstein, A.L.B. Ambrosio, S.M. Gomes Dias, G.A. Calin, Allele-specific reprogramming of cancer metabolism by the long non-coding RNA CCAT2. Mol. Cell 61, 520–534 (2016)CrossRefPubMedPubMedCentral

26.

M.D. Westfall, J.A. Pietenpol, p63: Molecular complexity in development and cancer. Carcinogenesis 25, 857–864 (2004)CrossRefPubMed

27.

M.J. Urist, C.J. Di Como, M.L. Lu, E. Charytonowicz, D. Verbel, C.P. Crum, T.A. Ince, F.D. McKeon, C. Cordon-Cardo, Loss of p63 expression is associated with tumor progression in bladder cancer. Am. J. Pathol. 161, 1199–1206 (2002)CrossRefPubMedPubMedCentral

28.

E. Pokidysheva, S. Boudko, J. Vranka, K. Zientek, K. Maddox, M. Moser, R. Fässler, J. Ware, H.P. Bächinger, Biological role of prolyl 3-hydroxylation in type IV collagen. Proc. Natl. Acad. Sci. U. S. A. 111, 161–166 (2014)CrossRefPubMed

29.

R. Shah, P. Smith, C. Purdie, P. Quinlan, L. Baker, P. Aman, A. Thompson, T. Crook, The prolyl 3-hydroxylases P3H2 and P3H3 are novel targets for epigenetic silencing in breast cancer. Br. J. Cancer 100, 1687–1696 (2009)CrossRefPubMedPubMedCentral

30.

J. Wang, X. Xu, Z. Liu, X. Wei, R. Zhuang, D. Lu, L. Zhou, H. Xie, S. Zheng, LEPREL1 expression in human hepatocellular carcinoma and its suppressor role on cell proliferation. Gastroenterol. Res. Pract. 2013, 109759 (2013)PubMedPubMedCentral

31.

G. Di Maro, F.M. Orlandella, T.C. Bencivenga, P. Salerno, C. Ugolini, F. Basolo, R. Maestro, G. Salvatore, Identification of targets of Twist1 transcription factor in thyroid cancer cells. J. Clin. Endocrinol. Metab. 99, E1617–E1626 (2014)CrossRefPubMed

32.

B.N. Howie, P. Donnelly, J. Marchini, A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet. 5, e1000529 (2009)CrossRefPubMedPubMedCentral

33.

J. Marchini, B. Howie, Genotype imputation for genome-wide association studies. Nat. Rev. Genet. 11, 499–511 (2010)CrossRefPubMed

34.

K.R. Rosenbloom, C.A. Sloan, V.S. Malladi, T.R. Dreszer, K. Learned, V.M. Kirkup, M.C. Wong, M. Maddren, R. Fang, S.G. Heitner, B.T. Lee, G.P. Barber, R.A. Harte, M. Diekhans, J.C. Long, S.P. Wilder, A.S. Zweig, D. Karolchik, R.M. Kuhn, D. Haussler, W.J. Kent, ENCODE data in the UCSC genome browser: Year 5 update. Nucleic Acids Res. 41, D56–D63 (2013)CrossRefPubMed

35.

A.P. Boyle, E.L. Hong, M. Hariharan, Y. Cheng, M.A. Schaub, M. Kasowski, K.J. Karczewski, J. Park, B.C. Hitz, S. Weng, J.M. Cherry, M. Snyder, Annotation of functional variation in personal genomes using RegulomeDB. Genome Res. 22, 1790–1797 (2012)CrossRefPubMedPubMedCentral

36.

M.L. Freedman, A.N.A. Monteiro, S.A. Gayther, G.A. Coetzee, A. Risch, C. Plass, G. Casey, M. De Biasi, C. Carlson, D. Duggan, M. James, P. Liu, J.W. Tichelaar, H.G. Vikis, M. You, I.G. Mills, Principles for the post-GWAS functional characterization of cancer risk loci. Nat. Genet. 43, 513–518 (2011)CrossRefPubMedPubMedCentral

37.

A.A. Kyriazis, A.P. Kyriazis, W.B. McCombs 3rd, W.D. Peterson Jr., Morphological, biological, and biochemical characteristics of human bladder transitional cell carcinomas grown in tissue culture and in nude mice. Cancer Res. 44, 3997–4005 (1984)PubMed

38.

J.M. Simon, P.G. Giresi, I.J. Davis, J.D. Lieb, Using formaldehyde-assisted isolation of regulatory elements (FAIRE) to isolate active regulatory DNA. Nat. Protoc. 7, 256–267 (2012)CrossRefPubMedPubMedCentral

39.

S. Wilkins, K.W. Zhang, I. Mahfuz, R. Quantin, N. D’Cruz, J. Hutson, M. Ee, D. Bagli, K. Aitken, F. Nga-Yin Fong, P. Kwok-Shing Ng, S. Kwok-Wing Tsui, W. Yin-Wan Fung, T. Banu, A. Thakre, K. Johar, E. Jaureguizar, L. Li, W. Cheng, Insertion/deletion polymorphisms in the ΔNp63 promoter are a risk factor for bladder exstrophy epispadias complex. PLoS Genet. 8, e1003070 (2012)CrossRefPubMedPubMedCentral

40.

J. Barrett, B. Fry, J. Maller, M. Daly, Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics 21, 263–265 (2005)CrossRefPubMed

41.

P. Mali, L. Yang, K.M. Esvelt, J. Aach, M. Guell, J.E. DiCarlo, J.E. Norville, G.M. Church, RNA-guided human genome engineering via Cas9. Science 339, 823–826 (2013)CrossRefPubMedPubMedCentral

42.

B. Chen, L.A. Gilbert, B.A. Cimini, J. Schnitzbauer, W. Zhang, G.W. Li, J. Park, E.H. Blackburn, J.S. Weissman, L.S. Qi, B. Huang, Dynamic imaging of genomic loci in living human cells by an optimized CRISPR/Cas system. Cell 155, 1479–1491 (2013)CrossRefPubMedPubMedCentral

43.

Cancer Genome Atlas Research Network, Comprehensive molecular characterization of urothelial bladder carcinoma. Nature 507, 315–322 (2014)CrossRef

44.

E. Cerami, J. Gao, U. Dogrusoz, B.E. Gross, S.O. Sumer, B.A. Aksoy, A. Jacobsen, C.J. Byrne, M.L. Heuer, E. Larsson, Y. Antipin, B. Reva, A.P. Goldberg, C. Sander, N. Schultz, The cBio cancer genomics portal: An open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2, 401–404 (2012)CrossRefPubMed

45.

J. Gao, B.A. Aksoy, U. Dogrusoz, G. Dresdner, B. Gross, S.O. Sumer, Y. Sun, A. Jacobsen, R. Sinha, E. Larsson, E. Cerami, C. Sander, N. Schultz, Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci. Signal. 6, pl1 (2013)CrossRefPubMedPubMedCentral

46.

R.J. Pruim, R.P. Welch, S. Sanna, T.M. Teslovich, P.S. Chines, T.P. Gliedt, M. Boehnke, G.R. Abecasis, C.J. Willer, D. Frishman, LocusZoom: Regional visualization of genome-wide association scan results. Bioinformatics 26, 2336–2337 (2011)CrossRef

47.

W.J. Kent, C.W. Sugnet, T.S. Furey, K.M. Roskin, T.H. Pringle, A.M. Zahler, D. Haussler, The human genome browser at UCSC. Genome Res. 12, 996–1006 (2002)CrossRefPubMedPubMedCentral

48.

A.E. Sayan, B. D’Angelo, B.S. Sayan, P. Tucci, A. Cimini, M.P. Cerù, R.A. Knight, G. Melino, p73 and p63 regulate the expression of fibroblast growth factor receptor 3. Biochem. Biophys. Res. Commun. 394, 824–828 (2010)CrossRefPubMed

49.

Z. Du, J. Li, L. Wang, C. Bian, Q. Wang, L. Liao, X. Dou, X. Bian, R.C. Zhao, Overexpression of ΔNp63α induces a stem cell phenotype in MCF7 breast carcinoma cell line through the Notch pathway. Cancer Sci. 101, 2417–2424 (2010)CrossRefPubMed

50.

V.G. Cheung, R.S. Spielman, Genetics of human gene expression: Mapping DNA variants that influence gene expression. Nat. Rev. Genet. 10, 595–604 (2009)CrossRefPubMedPubMedCentral

51.

M. Burger, J.W.F. Catto, G. Dalbagni, H.B. Grossman, H. Herr, P. Karakiewicz, W. Kassouf, L.A. Kiemeney, C. La Vecchia, S. Shariat, Y. Lotan, Epidemiology and risk factors of urothelial bladder cancer. Eur. Urol. 63, 234–241 (2013)CrossRefPubMed

52.

O. Corradin, P.C. Scacheri, Enhancer variants: evaluating functions in common disease. Genome Med. 6, 85 (2014)CrossRefPubMedPubMedCentral

53.

X. Liang, J. Potter, S. Kumar, N. Ravinder, J.D. Chesnut, Enhanced CRSIPR/Cas9-mediated precise genome editing by improved design and delivery of gRNA, Cas9 nuclease, and donor DNA. J. Biotechnol. 241, 136–146 (2017)CrossRefPubMed

54.

Q. Li, J.H. Seo, B. Stranger, A. McKenna, I. Pe’Er, T. Laframboise, M. Brown, S. Tyekucheva, M.L. Freedman, Integrative eQTL-based analyses reveal the biology of breast cancer risk loci. Cell 152, 633–641 (2013)CrossRefPubMedPubMedCentral

55.

W. Li, M. Liu, Y. Feng, Y.F. Huang, Y.F. Xu, J.P. Che, G.C. Wang, J.H. Zheng, High expression of Notch ligand Jagged2 is associated with the metastasis and recurrence in urothelial carcinoma of bladder. Int. J. Clin. Exp. Pathol. 6, 2430–2440 (2013)PubMedPubMedCentral

56.

T. Rampias, P. Vgenopoulou, M. Avgeris, A. Polyzos, K. Stravodimos, C. Valavanis, A. Scorilas, A. Klinakis, A new tumor suppressor role for the Notch pathway in bladder cancer. Nat. Med. 20, 1199–1205 (2014)CrossRefPubMed

57.

A. Maraver, P.J. Fernandez-Marcos, T.P. Cash, M. Mendez-Pertuz, M. Dueñas, P. Maietta, P. Martinelli, M. Muñoz-Martin, M. Martínez-Fernandez, M. Cañamero, G. Roncador, J.L. Martinez-Torrecuadrada, D. Grivas, J.L. De La Pompa, A. Valencia, J.M. Paramio, F.X. Real, M. Serrano, NOTCH pathway inactivation promotes bladder cancer progression. J. Clin. Invest. 125, 824–830 (2015)CrossRefPubMedPubMedCentral

58.

D.C. Harmes, E. Bresnick, E.A. Lubin, J.K. Watson, K.E. Heim, J.C. Curtin, A.M. Suskind, J. Lamb, J. DiRenzo, Positive and negative regulation of deltaN-p63 promoter activity by p53 and deltaN-p63-alpha contributes to differential regulation of p53 target genes. Oncogene 22, 7607–7616 (2003)CrossRefPubMed

59.

Y. He, X. Wu, W. Tang, D. Tian, C. Luo, Z. Yin, H. Du, Impaired delta Np63 expression is associated with poor tumor development in transitional cell carcinoma of the bladder. J. Korean Med. Sci. 23, 825–832 (2008)CrossRefPubMedPubMedCentral

60.

Y.F. He, D.Y. Tian, Z.J. Yi, Z.K. Yin, C.L. Luo, W. Tang, X.H. Wu, Upregulation of cell adhesion through delta Np63 silencing in human 5637 bladder cancer cells. Asian J. Androl. 14, 788–792 (2012)CrossRefPubMedPubMedCentral

61.

H.O. Lee, J.H. Lee, E. Choi, J.Y. Seol, Y. Yun, H. Lee, A dominant negative form of p63 inhibits apoptosis in a p53-independent manner. Biochem. Biophys. Res. Commun. 344, 166–172 (2006)CrossRefPubMed

62.

H. Fukushima, F. Koga, S. Kawakami, Y. Fujii, S. Yoshida, E. Ratovitski, B. Trink, K. Kihara, Loss of ΔNp63promotes invasion of urothelial carcinomas via N-cadherin/Src homology and collagen/extracellular signal-regulated kinase pathway. Cancer Res. 69, 9263–9270 (2009)CrossRefPubMed

63.

S.P. Lerner, D.J. McConkey, K.A. Hoadley, K.S. Chan, W.Y. Kim, F. Radvanyi, M. Höglund, F.X. Real, Bladder cancer molecular taxonomy: Summary from a consensus meeting. Bladder Cancer 2, 37–47 (2016)CrossRefPubMedPubMedCentral

64.

G. Sjödahl, M. Lauss, K. Lövgren, G. Chebil, S. Gudjonsson, S. Veerla, O. Patschan, M. Aine, M. Fernö, M. Ringnér, W. Månsson, F. Liedberg, D. Lindgren, M. Höglund, A molecular taxonomy for urothelial carcinoma. Clin. Cancer Res. 18, 3377–3386 (2012)CrossRefPubMed

65.

W. Choi, S. Porten, S. Kim, D. Willis, E.R. Plimack, J. Hoffman-Censits, B. Roth, T. Cheng, M. Tran, I.L. Lee, J. Melquist, J. Bondaruk, T. Majewski, S. Zhang, S. Pretzsch, K. Baggerly, A. Siefker-Radtke, B. Czerniak, C.P. Dinney, D.J. McConkey, Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy. Cancer Cell 25, 152–165 (2014)CrossRefPubMedPubMedCentral

66.

P. Eriksson, M. Aine, S. Veerla, F. Liedberg, G. Sjödahl, M. Höglund, Molecular subtypes of urothelial carcinoma are defined by specific gene regulatory systems. BMC Med. Genet. 8, 25 (2015)

67.

L. Boldrup, P. J. Coates, X. Gu, K. Nylander, ΔNp63 isoforms regulate CD44 and keratins 4, 6, 14 and 19 in squamous cell carcinoma of head and neck. J. Pathol. 213, 384–391 (2007)CrossRefPubMed

68.

R.A. Romano, K. Ortt, B. Birkaya, K. Smalley, S. Sinha, An active role of the ΔN isoform of p63 in regulating basal keratin genes K5 and K14 and directing epidermal cell fate. PLoS One 4, e5623 (2009)CrossRefPubMedPubMedCentral

69.

S. Koutros, D. Baris, A. Fischer, W. Tang, M. Garcia-Closas, M.R. Karagas, M. Schwenn, A. Johnson, J. Figueroa, R. Waddell, L. Prokunina-Olsson, N. Rothman, D.T. Silverman, Differential urinary specific gravity as a molecular phenotype of the bladder cancer genetic association in the urea transporter gene, SLC14A1. Int. J. Cancer 133, 3008–3013 (2013)PubMedPubMedCentral

70.

M. Wang, M. Du, L. Ma, H. Chu, Q. Lv, D. Ye, J. Guo, C. Gu, G. Xia, Y. Zhu, Q. Ding, L. Yuan, G. Fu, N. Tong, C. Qin, C. Yin, J. Xu, Z. Zhang, A functional variant in TP63 at 3q28 associated with bladder cancer risk by creating an miR-140-5p binding site. Int. J. Cancer 139, 65–74 (2016)CrossRefPubMed

Title: Identification of an enhancer region within the TP63/LEPREL1 locus containing genetic variants associated with bladder cancer risk
Authors: Aleksandra M. Dudek
Sita H. Vermeulen
Dimitar Kolev
Anne J. Grotenhuis
Lambertus A. L. M. Kiemeney
Gerald W. Verhaegh
Publication date: 01-10-2018
Publisher: Springer Netherlands
Published in: Cellular Oncology / Issue 5/2018
Print ISSN: 2211-3428
Electronic ISSN: 2211-3436
DOI: https://doi.org/10.1007/s13402-018-0393-5

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 5/2018

Stromal collagen type VI associates with features of malignancy and predicts poor prognosis in salivary gland cancer

TLR4 and RAGE conversely mediate pro-inflammatory S100A8/9-mediated inhibition of proliferation-linked signaling in myeloproliferative neoplasms

β-Catenin gene promoter hypermethylation by reactive oxygen species correlates with the migratory and invasive potentials of colon cancer cells

Correction to: β-Catenin gene promoter hypermethylation by reactive oxygen species correlates with the migratory and invasive potentials of colon cancer cells

Mesenchymal marker and LGR5 expression levels in circulating tumor cells correlate with colorectal cancer prognosis

Interplay between NRF1, E2F4 and MYC transcription factors regulating common target genes contributes to cancer development and progression

Keynote webinar | Spotlight on antibody–drug conjugates in cancer